| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/28/2006 | EP1107762B9 Use of misoprostol or/and misoprostol acid for preparing drug in order to cure sexual dysfunction in women |
| 06/28/2006 | EP1073439B1 Pharmaceutical composition |
| 06/28/2006 | EP1061922B1 Use of n-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds for treating hepatitis virus infections |
| 06/28/2006 | EP1041990B1 Composition for treating respiratory and skin diseases, comprising at least one leukotriene antagonist and at least one antihistamine |
| 06/28/2006 | EP1040185B9 Neural precursor cells, method for the production and use thereof in neural defect therapy |
| 06/28/2006 | EP1017364A4 Inorganic-polymer complexes for the controlled release of compounds including medicinals |
| 06/28/2006 | EP1011638A4 Small particle liposome aerosols for delivery of anti-cancer drugs |
| 06/28/2006 | EP1007053B1 Treatment of pain |
| 06/28/2006 | EP0990041B1 Regulation of transcription in mammalian cells and viral replication by a tetracyclin repressor |
| 06/28/2006 | EP0951281B1 2-CYCLOPENTEN-1-ONE AND ITS DERIVATIVES AS INHIBITORS OF THE NF-kappa B FACTOR |
| 06/28/2006 | EP0924213B1 Pyridobenzoxazine derivatives |
| 06/28/2006 | EP0914103B1 Treatment of a hemoglobinopathy |
| 06/28/2006 | EP0897426B1 Matrix metalloprotease |
| 06/28/2006 | EP0895543B1 Method of stimulating an immune response by administration of host organisms that express intimin alone or as a fusion protein with one or more other antigens |
| 06/28/2006 | EP0876143B1 Tumor necrosis factor alpha (tnf-alpha) inhibiting pharmaceuticals |
| 06/28/2006 | EP0870503B9 use of vitamin D derivatives for the manufacture of a medicament for treating MALIGNANT TUMOR METASTASIS |
| 06/28/2006 | EP0832227B9 Method for prolonging the expression of a gene of interest using soluble ctla4 molecules |
| 06/28/2006 | EP0820307B1 Increasing the hdl level and the hdl/ldl ratio in human serum by balancing saturated and polyunsaturated dietary fatty acids |
| 06/28/2006 | EP0797676B9 Recombinant adenoviral vector and methods of use |
| 06/28/2006 | EP0693129B1 Method of inhibiting the transcription of genes |
| 06/28/2006 | CN1795388A Diagnostic kit for liver cirrhosis comprising an antibody specific for human protooncogenic protein |
| 06/28/2006 | CN1795274A Selected rna motifs to include cell death and/or apoptosis |
| 06/28/2006 | CN1795220A Process of making press molded materials using heat activated tertiary amine urethane catalysts |
| 06/28/2006 | CN1795205A Spex compositions and methods of use |
| 06/28/2006 | CN1795196A Agent for repairing corneal sensitivity containing amide compound |
| 06/28/2006 | CN1795195A Pyridopyrazines and the use thereof as kinase inhibitors |
| 06/28/2006 | CN1795194A Pyridopyrazines and the use thereof as kinase inhibitors |
| 06/28/2006 | CN1795193A N-acyl nitrogen heterocyles as ligands of peroxisome proliferator-activated receptors |
| 06/28/2006 | CN1795190A Compounds and methods for the treatment or prevention of flavivirus infections |
| 06/28/2006 | CN1795188A Inhibitors of serine proteases, particularly hcv ns3-ns4a protease |
| 06/28/2006 | CN1795186A Di-aryl substituted triazole modulators of metabotropic glutamate receptor-5 |
| 06/28/2006 | CN1795183A Hydroxyamidine and hydroxyguanidine compounds as urokinase inhibitors |
| 06/28/2006 | CN1795181A Triazole derivatives as inhibitors of 11-beta hydroxysteroid dehydrogenase-1 |
| 06/28/2006 | CN1795180A Novel quinazoline derivatives and methods of treatment related to the use thereof |
| 06/28/2006 | CN1795179A Novel imidazole derivatives, the production thereof, and the use of the same as a medicament |
| 06/28/2006 | CN1795176A Azabicyclo derivatives as muscarinic receptor antagonists |
| 06/28/2006 | CN1795175A Acetylene derivatives as inhibitors of histone deacetylase |
| 06/28/2006 | CN1795174A Novel substituted 3-sulfur indoles |
| 06/28/2006 | CN1795173A Captopril derivatives |
| 06/28/2006 | CN1795169A Crystalline form of beta2 adrenergic receptor agonist |
| 06/28/2006 | CN1795163A Carboxylic compound and medicine comprising the same |
| 06/28/2006 | CN1795162A Process of making press molded materials using heat activated tertiary amine urethane catalysts |
| 06/28/2006 | CN1795013A Compositions for treating infection in cattle and swine |
| 06/28/2006 | CN1795011A A pharmaceutical composition comprising a p2x7-receptor antagonist and a tumour necrosis factor alpha |
| 06/28/2006 | CN1795003A Anti-inflammatory composition based on strontium compounds |
| 06/28/2006 | CN1795002A Rock flour, especially dolomite-based medicament, for the treatment of cancer diseases |
| 06/28/2006 | CN1795001A Medicament for internal application, in particular against cancerous diseases |
| 06/28/2006 | CN1795000A Compositions containing lactulose for treating potavirus infections |
| 06/28/2006 | CN1794999A Remedy for nerve damage |
| 06/28/2006 | CN1794998A Foamable pharmaceutical compositions and methods for treating a disorder |
| 06/28/2006 | CN1794997A 2,3,4,5-tetrahydrobenzo[f][1,4]oxazepine-5-carboxylic acid amide derivatives as gamma-secretase inhibitors for the treatment of alzheimer's disease |
| 06/28/2006 | CN1794996A Macrocyclic quinazoline derivatives as antiproliferative agents |
| 06/28/2006 | CN1794995A Use of tyrosine kinase inhibitor to treat diabetes |
| 06/28/2006 | CN1794994A Carbostyril derivatives and mood stabilizers for treating mood disorders |
| 06/28/2006 | CN1794993A Medicinal composition containing benidipine hydrochloride |
| 06/28/2006 | CN1794992A Method for treating mild cognitive impairment and for preventing or delaying alzheimeracoes disease |
| 06/28/2006 | CN1794991A Pharmaceutical composition containing histone deacetylase inhibitor |
| 06/28/2006 | CN1794990A Di-aryl substituted pyrrole modulators of metabotropic glutamate receptor-5 |
| 06/28/2006 | CN1794989A N-(((((1,3-thiazol-2-yl)amino)carbonyl)phenyl)sulfonyl)phenylalanine derivatives and related compounds for the treatment of diabetes |
| 06/28/2006 | CN1794988A Method for treating vascular hyperpermeable disease |
| 06/28/2006 | CN1794987A Nitrooxyderivatives of fluvastatin, pravastatin, cerivastatin, atorvastatin and rosuvastatin as cholesterol-reducing agents with improved anti-inflammatory, antithrombotic and antiplatelet activity |
| 06/28/2006 | CN1794986A Novel methods for the treatment of cancer |
| 06/28/2006 | CN1794985A Azabicyclo derivatives as muscarinic receptor antagonists |
| 06/28/2006 | CN1794984A Substituted azabicyclo hexane derivatives as muscarinic receptor antagonists |
| 06/28/2006 | CN1794983A Aqueous olanexidine solution, method of preparing the same, and disinfectant |
| 06/28/2006 | CN1794982A Use of compounds for the prevention of drug-induced cell toxicity |
| 06/28/2006 | CN1794981A Combination of an nmda receptor antagonist and a selective serotonin reuptake inhibitor for the treatment of depression and other mood disorders |
| 06/28/2006 | CN1794980A Temporary embolization using inverse thermosensitive polymers |
| 06/28/2006 | CN1794978A Pharmaceutical compositions comprising atorvastatin manufactured without granulation |
| 06/28/2006 | CN1794977A Antimicrobial quaternary ammonium organosilane coatings |
| 06/28/2006 | CN1794976A Dietary supplement and method for the treatment and prevention of digestive tract ulcers in equines and other animals |
| 06/28/2006 | CN1794975A Formulation to render an antimicrobial drug potent against organisms normally considered to be resistant to the drug |
| 06/28/2006 | CN1794974A 药物递送体系 Drug delivery system |
| 06/28/2006 | CN1794973A Preserved ophthalmic compositions |
| 06/28/2006 | CN1794925A Novel nutraceutical compositions and use thereof |
| 06/28/2006 | CN1794915A Aqueous compositions for disinfection and/or sterilization |
| 06/28/2006 | CN1793182A Process for preparing dual-philic N,N-di-acylating shellglycan |
| 06/28/2006 | CN1793156A Luteolin-7-O-bata-glucuronide and its extracting process and application thereof |
| 06/28/2006 | CN1793155A 4'-substituted-9-deoxo-9a-aza-9a-homoerythromycin a derivatives |
| 06/28/2006 | CN1793154A 3,5-di-0-(4-chlorobenzoyl)-2-deoxide-D-erythro-furan glucoside and preparation process thereof |
| 06/28/2006 | CN1793146A Process for the production of 9-pyro-3, 7-biazobicyclononane(3.3.1) |
| 06/28/2006 | CN1793145A 7-bit substituted comptothecine kind compound and pharmaceutical use thereof |
| 06/28/2006 | CN1793132A Derivative of cyclo membranousol kind and application thereof |
| 06/28/2006 | CN1793128A Anti anaerbic bacterial compound |
| 06/28/2006 | CN1793120A Thiourea kind compund with inhibiting virus capsid protain activity and its preparation process and application thereof |
| 06/28/2006 | CN1793108A Haptenic compound of clenbuterol synthesizing process and application thereof |
| 06/28/2006 | CN1793104A Process for extracting high purity alpha-linolenic acid from pepper category and medicine application thereof |
| 06/28/2006 | CN1793087A Total triterpenoid extract fine thim asterium sponge and its preparation process and application thereof |
| 06/28/2006 | CN1792380A Digestive tract stent with anti-cancer medicinal particles |
| 06/28/2006 | CN1792370A External use prepns. for wind-dispelling, removing-obstruction in channels to relieve pain |
| 06/28/2006 | CN1792364A Medicinal composition contg. stavudine and valproic acid or salts thereof |
| 06/28/2006 | CN1792363A Medicinal composition contg. IDV and valproic acid or salts thereof |
| 06/28/2006 | CN1792362A Abiduoer and its salts prepns. for vena administration, and its preparing method |
| 06/28/2006 | CN1792361A Compound medicine composition for treating hepatitis effectively |
| 06/28/2006 | CN1792250A Nutrient food for reducing-weight, preventing and treating fatty liver disease, and its prodn. method |
| 06/28/2006 | CN1792247A Health-care food with functions of anti-senium and cosmetic |
| 06/28/2006 | CN1261593C Use of IC 53 gene and its related product in diagnosing and treating colon cancer and reagent box for diagnosing colon canter |
| 06/28/2006 | CN1261592C Antigen polypeptide of IC53 gene product, use of auto-body in diagnosis and treating of arrhythmia cardimyopathy and reagent kit containing the polypeptide |
| 06/28/2006 | CN1261453C Platelet-derived growth factor D, DNA coding and uses thereof |
| 06/28/2006 | CN1261450C Antithrombotic compounds |